Joan L. Cmarik

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

Joan L. Cmarik, Hongzhong Min, Glenn Hegamyer et al. · Proceedings of the National Academy of Sciences · 1999 · 254 citations · Full text

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation

Hsin‐Sheng Yang, Aaron P. Jansen, Rajalakshmi Nair et al. · Oncogene · 2001 · 186 citations

Signal Transduction, Signaling Pathway, Molecular Pathway +11

Covalent binding of 1,2-dihaloalkanes to DNA and stability of the major DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione.

Philip B. Inskeep, Naofumi Koga, Joan L. Cmarik et al. · PubMed · 1986 · 91 citations

Lipid Peroxidation, Dna Analysis, Molecular Biology +22

Mutation spectrum and sequence alkylation selectivity resulting from modification of bacteriophage M13mp18 DNA with S-(2-chloroethyl)glutathione. Evidence for a role of S-(2-N7-guanyl)ethyl)glutathione as a mutagenic lesion formed from ethylene dibromide.

Joan L. Cmarik, W. Griffith Humphreys, K L Bruner et al. · Journal of Biological Chemistry · 1992 · 60 citations · Full text

Genetics, Bacteriology, Bacteriophage +17

Comparison of the DNA-alkylating properties and mutagenic responses of a series of S-(2-haloethyl)-substituted cysteine and glutathione derivatives

W. Griffith Humphreys, Dong‐Hyun Kim, Joan L. Cmarik et al. · Biochemistry · 1990 · 56 citations

Nucleic Acid Chemistry, Mutagenic Responses, Biochemistry +10